The company, specializing in the development of technological solutions for implantology and rehabilitation, will compete in the national gala to be held in Logroño on November 18th. Bioréplica was chosen after a selection process among 367 candidacies from across the country.
At the event, Bioréplica will have one minute to present its project to an audience composed of professionals from the entrepreneurial, business, investor, and institutional ecosystems. The program's activities will continue until November 19th with conferences, debate panels, and networking events designed to foster knowledge exchange and create business and investment opportunities.
The Top 101 Spain Up Nation initiative, driven by Foro ADR in collaboration with the National Innovation Company (Enisa) and the Economic Development Agency of La Rioja (ADER), aims to identify and showcase innovative and technology-based companies with high growth potential and the capacity to generate economic, social, and environmental impact.
Bioréplica's selection highlights its commitment to technology applied to the biomedical field and reinforces the presence of ULPGC startups in national initiatives. It also validates the work of the University's Knowledge Transfer Office in promoting and supporting the creation of knowledge-based companies.
